These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8583775)
1. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype. Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775 [TBL] [Abstract][Full Text] [Related]
2. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes. Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog. Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models. Lacour C; Canals F; Galindo G; Cazaubon C; Segondy D; Nisato D Eur J Pharmacol; 1994 Nov; 264(3):307-16. PubMed ID: 7698170 [TBL] [Abstract][Full Text] [Related]
5. Pharmacology and pharmacokinetics of a novel nonpeptide angiotensin II receptor antagonist--DMP 811. Wong PC; Huang SM; Ardecky RJ; Carini DJ; Chiu AT; Price WA; Agra AM; Wexler RR; Timmermans PB Clin Exp Hypertens; 1995 Nov; 17(8):1233-56. PubMed ID: 8563699 [TBL] [Abstract][Full Text] [Related]
6. Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors. Quan ML; Chiu AT; Ellis CD; Wong PC; Wexler RR; Timmermans PB J Med Chem; 1995 Jul; 38(15):2938-45. PubMed ID: 7636854 [TBL] [Abstract][Full Text] [Related]
7. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist. Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist. Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist. Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249 [TBL] [Abstract][Full Text] [Related]
11. Binding of valsartan to mammalian angiotensin AT1 receptors. de Gasparo M; Whitebread S Regul Pept; 1995 Nov; 59(3):303-11. PubMed ID: 8577935 [TBL] [Abstract][Full Text] [Related]
12. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism. Haddad G; Amiri F; Garcia R Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382 [TBL] [Abstract][Full Text] [Related]
13. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats. Morita O; Kushida H; Kunihara M J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332 [TBL] [Abstract][Full Text] [Related]
14. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats. Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000 [TBL] [Abstract][Full Text] [Related]
15. The pharmacologic profile of 606A, a novel angiotensin II receptor antagonist. Hashimoto Y; Harada Y; Narita H; Naito K; Murata S J Cardiovasc Pharmacol; 1997 Feb; 29(2):284-90. PubMed ID: 9057080 [TBL] [Abstract][Full Text] [Related]
16. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats. Toney GM; Porter JP Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041 [TBL] [Abstract][Full Text] [Related]
17. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes. Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905 [TBL] [Abstract][Full Text] [Related]
18. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist. Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys. Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo. Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]